Framatome, KHNP to investigate producing Lu-177 in South Korea

April 19, 2024, 7:01AMNuclear News
Catherine Cornand of Framatome and Chang Hee-Seung of KHNP (center) with Framatome and KHNP employees following the signing of the MOU. (Photo: Framatome)

Framatome and Korea Hydro & Nuclear Power (KHNP) have announced the signing of a memorandum of understanding to explore the possibility of producing the medical isotope lutetium-177 at KHNP’s Wolsong nuclear power plant in South Korea. The companies also will investigate the feasibility of using the plant to support Korean production of medical radioisotopes in the future.

To continue reading, log in or create a free account!

Related Articles